ATE338130T1 - Cdna für humane methyllentetrahydrofolatreduktase - Google Patents

Cdna für humane methyllentetrahydrofolatreduktase

Info

Publication number
ATE338130T1
ATE338130T1 AT95919289T AT95919289T ATE338130T1 AT E338130 T1 ATE338130 T1 AT E338130T1 AT 95919289 T AT95919289 T AT 95919289T AT 95919289 T AT95919289 T AT 95919289T AT E338130 T1 ATE338130 T1 AT E338130T1
Authority
AT
Austria
Prior art keywords
human
patients
mthfr
cdna
reductase
Prior art date
Application number
AT95919289T
Other languages
English (en)
Inventor
Rima Rozen
Philippe Goyette
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE338130T1 publication Critical patent/ATE338130T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95919289T 1994-05-26 1995-05-25 Cdna für humane methyllentetrahydrofolatreduktase ATE338130T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9410620A GB9410620D0 (en) 1994-05-26 1994-05-26 cDNA for human mehylenetetrahydrofolate reductase

Publications (1)

Publication Number Publication Date
ATE338130T1 true ATE338130T1 (de) 2006-09-15

Family

ID=10755786

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919289T ATE338130T1 (de) 1994-05-26 1995-05-25 Cdna für humane methyllentetrahydrofolatreduktase

Country Status (9)

Country Link
US (4) US6074821A (de)
EP (2) EP1752539A2 (de)
AT (1) ATE338130T1 (de)
AU (1) AU2519895A (de)
CA (1) CA2191220C (de)
DE (1) DE69535204T2 (de)
ES (1) ES2271946T3 (de)
GB (1) GB9410620D0 (de)
WO (1) WO1995033054A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410620D0 (en) * 1994-05-26 1994-07-13 Univ Mcgill cDNA for human mehylenetetrahydrofolate reductase
US6566065B1 (en) * 1994-05-26 2003-05-20 Mcgill University Method of diagnosing schizophrenia by detecting a mutation in the (MTHFR) gene
EP1097222A1 (de) * 1998-07-15 2001-05-09 E.I. Du Pont De Nemours And Company Enzyme des tetrahydrofolatmetabolismus
US6759200B1 (en) 1998-07-20 2004-07-06 Nuvelo, Inc. Thymidine phosphorylase gene sequence variances having utility in determining the treatment of disease
US6664062B1 (en) * 1998-07-20 2003-12-16 Nuvelo, Inc. Thymidylate synthase gene sequence variances having utility in determining the treatment of disease
US20050191691A1 (en) * 1998-07-20 2005-09-01 Variagenics, Inc., A Delaware Corporation Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease
EP1652936A3 (de) * 1999-03-01 2006-06-14 McGILL UNIVERSITY cDNA von menschlicher Methylentetrahydrofolatreductase
US20010025030A1 (en) * 1999-03-01 2001-09-27 Rima Rozen cDNA for human methylenetetrahydrofolate reductase and uses thereof
AU781645B2 (en) * 1999-03-01 2005-06-02 Mcgill University cDNA for human methylenetetrahydrofolate reductase
US6912492B1 (en) 1999-05-25 2005-06-28 University Of Medicine & Dentistry Of New Jersey Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
FR2811321A1 (fr) * 2000-07-04 2002-01-11 Bio Merieux Amplificateur d'une region ribonucleique cible d'un arn ribosomal 16s ou adn pour un tel arn d'une espece eubacterienne et detection de telles especes
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
CN1155722C (zh) * 2001-04-02 2004-06-30 四川宇康生物技术有限公司 孕前基因报警诊断试剂盒及其检测方法
JP4174203B2 (ja) * 2001-10-11 2008-10-29 オキサゲン リミティッド 骨損傷の受け易さを判定する方法
JP2005500246A (ja) 2001-12-03 2005-01-06 マギル ユニヴァーシティー メチレンテトラヒドロ葉酸還元酵素阻害剤およびそれらの使用
US20030198985A1 (en) * 2002-02-22 2003-10-23 Hogan Kirk J. Assay for nitrous oxide neurologic syndrome
WO2003078574A2 (en) * 2002-03-11 2003-09-25 Lipomics Technologies, Inc. Novel metabolic targets and markers
KR20030081967A (ko) * 2002-04-15 2003-10-22 최병옥 뇌경색의 예측 또는 예방을 위한 ｍｔｈｆｒ 677ｔｔ유전자형
ATE538128T1 (de) 2002-09-05 2012-01-15 Techlab Inc Verfahren zur unterscheidung von colitis ulcerosa von morbus crohn durch nachweis des vorliegens von fäkalen anti-neutrophilen cytoplasmatischen antikörpern (anca)
JP2011519267A (ja) * 2008-03-27 2011-07-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 代謝経路に関与する遺伝子の障害アレル並びにそれを検出及び使用する方法
RU2622082C2 (ru) 2011-11-14 2017-06-09 Нестек С.А. Анализы и способы выбора режима лечения пациента с депрессией

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410620D0 (en) * 1994-05-26 1994-07-13 Univ Mcgill cDNA for human mehylenetetrahydrofolate reductase
US5972614A (en) 1995-12-06 1999-10-26 Genaissance Pharmaceuticals Genome anthologies for harvesting gene variants
US6008221A (en) 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
AU768810B2 (en) 1998-07-20 2004-01-08 Century Technology, Inc. Gene sequence variances with utility in determining the treatment of disease

Also Published As

Publication number Publication date
WO1995033054A1 (en) 1995-12-07
CA2191220C (en) 2012-03-13
DE69535204D1 (de) 2006-10-12
US6218120B1 (en) 2001-04-17
EP1752539A2 (de) 2007-02-14
US6074821A (en) 2000-06-13
US6528259B1 (en) 2003-03-04
EP0755450B1 (de) 2006-08-30
ES2271946T3 (es) 2007-04-16
GB9410620D0 (en) 1994-07-13
AU2519895A (en) 1995-12-21
US20030157530A1 (en) 2003-08-21
DE69535204T2 (de) 2007-07-19
EP0755450A1 (de) 1997-01-29
CA2191220A1 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
ATE338130T1 (de) Cdna für humane methyllentetrahydrofolatreduktase
WO1996018738A3 (en) PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
DE69628758D1 (de) Identifikation von mutationen, die mit menschlicher alpha-thalassämie assoziiert sind, und ihre verwendung für die vorhersage von blutkrankheiten.
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
DE69635582D1 (de) Diagnostika und behandlungen von peridontalen erkrankungen
IL115792A0 (en) Al-1 neurothophic factor
DE69729954D1 (de) Identifizierungsverfahren für Substanzen die an das Pyk2 Polypeptid binden
NO20014417L (no) Vaskul¶re adhesjonsmolekyler samt modulering av deres funksjon
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
DE68928728D1 (de) Diagnose von retinoblastoma
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
WO1999033870A3 (en) Human regulatory proteins
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
ES2057572T3 (es) Agentes de reconocimiento.
TR200000416T2 (tr) Neisseria loctoferrin bağlayıcı protein.
DE69835519D1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind.
DE69836278D1 (de) Allele formen von menschlichem stat3
DE69840928D1 (de) Nachweismethoden für reagenzien, die das "inhibitor-der-apoptose-protein" (iap) regulieren und dadurch auf die caspaseaktivität einwirken
ATE312914T1 (de) Rdgb-proteine
BR0007816A (pt) Fator de estimulação óssea
NZ334762A (en) Human DNase I variants having binding affinity to actin
AU5569600A (en) Novel protein and dna thereof
Dayal et al. Adenosine deaminase activity in serum and lymphocytes of multibacillary leprosy patients
WO2003000729A3 (en) Secreted polypeptide and their use in the treatment of bone disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties